Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design and Evaluation of Nanoscale Materials with Programmed Responsivity towards Epigenetic Enzymes. | bioRxiv | 2024 | 38586020 | PubTator, text mining | PubMed |
| A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress. | Biomed Pharmacother | 2024 | 38579401 | PubTator, text mining | PubMed |
| MicroRNA-mediated epigenetic regulation of HDAC8 and HDAC6: Functional significance in cervical cancer. | Noncoding RNA Res | 2024 | 38577018 | PubTator, text mining | PubMed |
| Explicable prioritization of genetic variants by integration of rule-based and machine learning algorithms for diagnosis of rare Mendelian disorders. | Hum Genomics | 2024 | 38509596 | PubTator, text mining | PubMed |
| Epigenetic Switches in Retinal Homeostasis and Target for Drug Development. | Int J Mol Sci | 2024 | 38474086 | PubTator, text mining | PubMed |
| A proximity labeling-based orthogonal trap strategy identifies HDAC8 promotes cell motility by modulating cortactin acetylation. | Cell Chem Biol | 2024 | 38460516 | PubTator, text mining | PubMed |
| Effects of structurally distinct human HDAC6 and HDAC6/HDAC8 inhibitors against S. mansoni larval and adult worm stages. | PLoS Negl Trop Dis | 2024 | 38416775 | PubTator, text mining | PubMed |
| Influenza Virus Host Restriction Factors: The ISGs and Non-ISGs. | Pathogens | 2024 | 38392865 | PubTator, text mining | PubMed |
| Beyond the tail: the consequence of context in histone post-translational modification and chromatin research. | Biochem J | 2024 | 38353483 | PubTator, text mining | PubMed |
| Targeting histone deacetylase 9 represses fibrogenic phenotypes in buccal mucosal fibroblasts with arecoline stimulation. | J Dent Sci | 2024 | 38303807 | PubTator, text mining | PubMed |
| Epigenome-wide DNA methylation analysis of late-stage mild cognitive impairment. | Front Cell Dev Biol | 2024 | 38298218 | PubTator, text mining | PubMed |
| Quinazoline-chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in-silico studies of potential anticancer activity against multiple myeloma. | Arch Pharm (Weinheim) | 2024 | 38297894 | PubTator, text mining | PubMed |
| Identification of a Histone Deacetylase 8 Inhibitor through Drug Screenings Based on Machine Learning. | Chem Pharm Bull (Tokyo) | 2024 | 38296560 | PubTator, text mining | PubMed |
| CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma. | Cell Death Dis | 2024 | 38287022 | PubTator, text mining | PubMed |
| Mutation profiling in South African patients with Cornelia de Lange syndrome phenotype. | Mol Genet Genomic Med | 2024 | 38284454 | PubTator, text mining | PubMed |
| Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor. | Int J Mol Sci | 2024 | 38279359 | PubTator, text mining | PubMed |
| STAG2: Computational Analysis of Missense Variants Involved in Disease. | Int J Mol Sci | 2024 | 38279279 | PubTator, text mining | PubMed |
| Early Prenatal Diagnosis of Cornelia de Lange's Syndrome with Whole-Exome Sequencing: A Case Report. | AJP Rep | 2024 | 38269131 | PubTator, text mining | PubMed |
| A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance. | Acta Pharm Sin B | 2024 | 38261805 | PubTator, text mining | PubMed |
| Influenza A Virus and Acetylation: The Picture Is Becoming Clearer. | Viruses | 2024 | 38257831 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=10